کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2918013 1175681 2012 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Impact of Peripherally Established Cardiopulmonary Bypass on Regional and Systemic Blood Lactate Levels
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
پیش نمایش صفحه اول مقاله
Impact of Peripherally Established Cardiopulmonary Bypass on Regional and Systemic Blood Lactate Levels
چکیده انگلیسی

BackgroundTo investigate blood lactate levels during and after peripherally established cardiopulmonary bypass (CPB).MethodsIn 86 patients (41 males, mean age 13.8 ± 7.2), CPB was established via femoral vein and artery cannulation for thoracoscopic closure of atrial (n = 54) or ventricular septal defect (n = 32). Arterial and venous blood lactate levels were measured from the cannulated limb during CPB, and from systemic circulation after CPB.ResultsThe mean duration of CPB and cannulation of a lower extremity were 50.0 ± 10.5 min and 76.0 ± 18.5 min, respectively. The mean arterial lactate level measured from the systemic circulation remained unchanged during CPB (P > 0.05). In patients with CPB for 3 h or more, mean arterial lactate in the cannulated limb were higher than the baseline values (3.3 ± 0.5 vs 0.8 ± 0.2 mmol/L, P < 0.05). In patients with more than 2 h of CPB, mean venous lactate levels in the cannulated limb were also higher than the baseline values (3.4 ± 0.2 vs 1.1 ± 0.3 mmol/L, P < 0.05). Within 6 h after CPB, systemic arterial (3.0 ± 0.2 vs 0.8 ± 0.1 mmol/L, P < 0.01) and venous lactate levels (6.5 ± 0.2 vs 1.0 ± 0.1 mmol/L, P < 0.01) were higher than the pre-CPB values.ConclusionsPeripherally established CPB was associated with an arterial and venous lactate elevation in local and systemic circulation. The duration of CPB and lower limb cannulation appears to be related to the lactate elevation.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Heart, Lung and Circulation - Volume 21, Issue 3, March 2012, Pages 154–158
نویسندگان
, , , , , ,